Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbCellera Biologics

4.68
-0.0950-1.99%
Volume:1.24M
Turnover:5.83M
Market Cap:1.40B
PE:-8.35
High:4.80
Open:4.78
Low:4.58
Close:4.77
52wk High:5.82
52wk Low:1.89
Shares:298.83M
Float Shares:202.75M
Volume Ratio:2.33
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5598
EPS(LYR):-0.5533
ROE:-15.64%
ROA:-10.95%
PB:1.39
PE(LYR):-8.45

Loading ...

AbCellera Biologics Appoints New Chief Medical Officer

TIPRANKS
·
Sep 11

AbCellera Biologics Appoints Dr. Sarah Noonberg as Chief Medical Officer to Lead Clinical Development

Reuters
·
Sep 10

Abcellera Appoints DR. Sarah Noonberg as Chief Medical Officer

THOMSON REUTERS
·
Sep 10

Abcellera Doses First Participants in a Phase 1 Clinical Trial of Abcl575

THOMSON REUTERS
·
Aug 27

AbCellera Biologics Inc. to Participate in Wells Fargo Healthcare Conference

Reuters
·
Aug 13

Stock Track | AbCellera Biologics Plummets 5.19% as Stifel Cuts Target Price Despite Q2 Earnings Beat

Stock Track
·
Aug 08

AbCellera Biologics Is Maintained at Buy by Stifel

Dow Jones
·
Aug 08

AbCellera Biologics Q2 2025 Earnings Call Summary and Q&A Highlights: Transition to Clinical-Stage and Strategic Pipeline Expansion

Earnings Call
·
Aug 08

Abcellera Biologics Inc : Stifel Cuts Target Price to $7 From $8

THOMSON REUTERS
·
Aug 08

Stock Track | AbCellera Biologics Soars 17.69% Pre-Market on Stellar Q2 Earnings, Revenue Triples Estimates

Stock Track
·
Aug 08

Stock Track | AbCellera Biologics Surges 17.69% Pre-Market on Stellar Q2 Earnings, Revenue Triples Estimates

Stock Track
·
Aug 08

Stock Track | AbCellera Biologics Soars 18.63% as Q2 Revenue Triples, Beating Estimates

Stock Track
·
Aug 08

Canadian biotech firm AbCellera Q2 revenue beats estimates

Reuters
·
Aug 08

Stock Track | AbCellera Biologics Soars 6.13% After-Hours on Strong Q2 Earnings Beat

Stock Track
·
Aug 08

Stock Track | AbCellera Biologics Soars 6.13% After-Hours on Strong Q2 Earnings Beat

Stock Track
·
Aug 08

AbCellera Q2 Revenue USD 17.1 Million Vs. IBES Estimate USD 6.12 Million

Reuters
·
Aug 08

AbCellera Biologics Q2 EPS $(0.12) Beats $(0.15) Estimate, Sales $17.084M Beat $5.824M Estimate

Benzinga
·
Aug 08

AbCellera Biologics Is Maintained at Overweight by Keybanc

Dow Jones
·
Jul 14

Abcellera Biologics Inc. to Announce Second Quarter 2025 Financial Results

Reuters
·
Jul 08

AbCellera Biologics Coverage Assumed by Leerink Partners at Outperform

Dow Jones
·
Jul 07